DeGette Calls on Major Insulin Manufacturers to Answer Questions Regarding Access to Insulin

"These companies have long provided lifesaving and life-enhancing products to over 38 million individuals in the United States with diabetes. Many of those individuals rely on insulin to regulate blood sugar and lead a healthy life, including the 2 million Americans living with type 1 diabetes and many millions living with type 2 diabetes," the members wrote. "For those who rely on insulin, the availability of these products is a life-and-death matter and may not be easily switched to a different product. This year we have seen multiple supply disruptions in insulin across different manufacturers, including in the vials of short-acting insulin individuals with type 1 diabetes need for their insulin pumps.

"We are concerned that continued supply disruptions could severely impact access to care for patients with diabetes and remain steadfast in our commitment to ensure there are alternatives available that will not present challenges to their daily living. The steady, predictable supply of many forms of insulin is a critical public health need. As one of the major manufacturers of insulin, your company serves as a partner to the diabetes community and is a critical part of this public health infrastructure," the members closed.

The full letters can be (link is external)found (link is external)here(link is external).

###